Nonfasting and fasting insulin levels at 8 weeks of HFD were also significantly reduced in TSC2-KOPlacenta mice compared with controls, suggesting lack of hyperinsulinemia development in these animals under HFD treatment (Figure 5F). The gene discussed is TSC2; the disease is hyperinsulinism.